Advisory Board and Editors Genetics
Kirankumar S. Mysore
Professor of Plant Biology at the Samuel Roberts Noble Foundation, Ardmore, OK, USA. Adjunct professor at the Department of Entomology and Plant Pathology, Oklahoma State University, Stillwater, OK.
Sushma Naithani
Sushma Naithani is an Associate Professor Senior Research in the Department of Botany and Plant Pathology at Oregon State University, USA. The current focus of her research is on understanding information flow in living systems and how evolution shapes this flow using systems-level pathway modeling supported by high-quality biocuration, gene-orthology-based predictions, and analysis of omics data. She serves as a senior curator for the Plant Reactome knowledgebase. Sushma has authored 31 peer-reviewed refereed research articles in high-impact journals, including Nature, Nature Biotech, PNAS, etc. One of her research papers has been selected by the 'Faculty of 1000 Biology'. In addition, she has authored six book chapters and one Open Textbook (S. Naithani (2021): History and Science of Cultivated Plants published by Oregon State University Open Educational Resources, EBOOK ISBN: 978-1-955101-08-0, available at https://open.oregonstate.education/cultivatedplants). She is also an Associate Editor for Frontiers in Plant Science-Plant Biotechnology and served as the Editor-in-chief of the Current Plant Biology (2017-2023).
Irene L.G. Newton
Assistant Professor of Biology in the Microbiology section. Woodrow Wilson Foundation Fellow, Andrew Mellon fellow, and advisor to the Social Science Research Counsel, former Howard Hughes Medical Institute Predoctoral Fellow and former NSF postdoctoral fellow.
Tuan V. Nguyen
Dr. Nguyen is Distinguished Professor of Predictive Medicine at the School of Biomedical Engineering, University of Technology Sydney (Australia). He also holds joint appointments as Professor, St Vincent's Clinical School, University of New South Wales (UNSW Sydney); and adjunct Professor of Epidemiology and Biostatistics at the School of Medicine, University of Notre Dame Australia.
Nikolaos Nikoloudakis
Dr. Nikolaos Nikoloudakis is an Assistant Professor at the Cyprus University of Technology (CUT). He graduated (2002) from the Agricultural Biotechnology Department of the Agricultural University of Athens (AUA) and has a MSc in the field of plant biotechnology (2005). He obtained his PhD at the Plant Breeding and Biometry Laboratory (AUA) caring out research involving phylogenetic relationships of Avena species and the study of intergenomic modifications using interspecific hybrids of different ploidy levels (2009). Furthermore, he was a post-doc researcher and a special teaching staff at the Department of Agricultural Sciences, Biotechnology and Food Science (ABF) of the Cyprus University of Technology (2017-2022). He has also served as a technical manager of the national reference laboratories of the Hellenic Ministry of Rural Development and Food, regarding GMO detection in seed lots and the control of pathogenic viruses in plant reproductive material (2011-2016). He has contributed to the formation of research networks as a partner from CUT in several national and European projects and participates in several funded research projects (Horizon 2020, Horizon Europe, Prima, RIF and ECPGR). His main research interests are agricultural biotechnology, plant genetic resources, genotyping, and flow cytometry.
Corey Nislow
Corey Nislow's laboratory develops and uses cutting edge tools to address this central question: how can we understand the biological commonalities in all of the life sciences; from embryonic development, to the spread of infectious diseases to better ways to treat cancer. Each of these disciplines can be explained in the context of competition, interaction and evolution. His lab studies the interface between genes and the environment using parallel genome-wide screens, high throughput cell-based assays and next generation sequencing. Most recently, he and his scientific partner, Dr. Guri Giaever, are exploring how laboratory experiments can co-opt evolutionary processes to understand drug action. He enjoys teaching all aspects of biotechnology, genomics and drug discovery. He got his PhD from the University of Colorado, worked at several Biotechnology companies and was at Stanford and University of Toronto before joining UBC in 2013. He has published 161 papers and run 19 marathons.
Houtan Noushmehr
Associate scientist and professor of epigenomics and bioinformatics at the department of neurosurgery and genetics.
Rodrigo Nunes-da-Fonseca
Associate Professor at the Center for Ecology and Socio-Environmental Development of Macaé, (NUPEM), Federal University of Rio de Janeiro (UFRJ-Macaé). Affiliate Member of the Brazilian Academy of Sciences (2017-2021). Scientist of Our State at FAPERJ (2019-nowadays), PhD (2008) and Postdoctoral studies (2009) in Functional Genomics and Evolutionary Developmental Biology (Evo-Devo) at the University of Cologne, Germany.
Published more than 85 articles in specialized journals with more than 3500 citations (Google Scholar-Fator H = 24). He serves as a reviewer for several international journals (NAR, Cell Reports, Dev. Gen Evol, Dev. Biol, FEBS J, Plos One, Gene, among others) particularly in the evolutionary genetics of arthropod development.
Olorunseun O Ogunwobi
Dr. Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, and a PhD in molecular biology from the University of East Anglia, Norwich, United Kingdom. He was the Founding Director of the Hunter College Center for Cancer Health Disparities Research. He is now the Barnett Rosenberg Professor of Biochemistry and Molecular Biology and Chairperson in the Department of Biochemistry and Molecular Biology at Michigan State University. In addition, he will serve as Co-Director of the forthcoming Center for Cancer Health Equity Research (CCHER) at Michigan State University. He is a translational cancer biologist whose work focuses on molecular mechanisms of progression of solid organ cancers with racial disparities, and on approaches to leverage non-coding RNA biology for potential clinical applications in cancer. His work has been funded by the National Institutes of Health, New York State, Carnegie Corporation of New York, and the National Science Foundation, among others. Dr. Ogunwobi was a Founding Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants CA221704 and CA221705 from the National Cancer Institute. An author of 74 peer-reviewed journal articles and 3 book chapters, Dr. Ogunwobi has been issued 5 US patents for biotechnology inventions with potential clinical applications in cancer. He is the recipient of the 2022 Hunter College Presidential Award for Excellence in Scholarship or Creative Activity, and selected as a Jefferson Science Fellow by the National Academies of Sciences, Engineering, and Medicine, and as a Fellow of the Academy of Medicine Specialties of Nigeria. He is Co-Founder of UTR Therapeutics, Inc (winner of the 2023 XSeed Award from Deerfield), and NucleoBio, Inc.
Sonia MR Oliveira
Doctor Sonia Oliveira holds a Licenciatura in Biology (pre-Bologna) and a Master in Cellular and Molecular Biology from the University of Aveiro, where she also specialized in medicinal plants, toxicology, murine models, and spermatogenesis. In 2011 she moved to Australia to work in Reproductive Biological Sciences. She later explored the nerve-cancer connection in Cancer, namely in female cancers, and completed her Ph.D. in Human Physiology ( with a significant component in Medical Biochemistry and Neurophysiology) from the University of Newcastle (Australia) in 2018. She then worked with biomimetic systems and nanotechnology in diabetes and stem cells. She explored multiple methods for primary and secondary cell culture, always with a keen interest in histopathology, cell biology, and rare disorders. Participated in >40 event(s). (Co-)Supervised MSc dissertation(s) and final projects for course completion of LSc/BSc. And works mostly in the area(s) of Natural sciences with emphasis on Molecular and Cellular Biology, and Medical and Health Sciences with emphasis on Neurosciences, Cancer, Reproduction, Toxicology, Biotechnology, and Stem cells. Also has collaborations in Microbiology, Biomaterials, and Communication and Information technologies.
Karen Osborn
Midwater biologist by way of Western Washington University, Monterey Bay Aquarium Research Institute (MBARI), University of California Berkeley, Scripps Institution of Oceanography, Smithsonian National Museum of Natural History.
Hilal Ozdag
Dr. Özdağ took her BSc in Biology from Hacettepe University Department of Biology on 1993. She then get her MSc degree in Biotechnology from the same department on 1995. Dr. Özdağ got her PhD on 2000 from Bilkent University Department of Molecular Biology and Genetics. Her PhD dissertation was on Hereditary Breast Cancer Genetics in Turkish Population. Dr. Özdağ then moved to UK for her postdoctoral studies. As a postdoctoral research associate at Prof. Caldas’s Laboratory in Cambridge University Hutchison-MRC Research Centre Dr. Özdağ worked on chromatin modifier genes in epithelial cancers.
Dr. Özdağ is leading her own research group at Ankara University Biotechnology Institute, Systems Biotechnology Advanced Research Unit (SISBIOTEK) since 2005. The team is conducting studies aiming to discover theranostic marker for colorectal cancer.